ESR1 and triple-negative breast carcinoma: Collectively, these data suggest that cholesterol increases glycolysis rates in triple-negative breast cancer cells, such as MDA-MB-231 and TNBC-PDX cells; however, it does not alter this pathway in ER+ breast cancer cells, such as MCF-7 cells.